Evidence map›Paper›PMID 30901841›Full record

ArticleInternational journal of molecular sciences2019

A Dual Molecular Biointerface Combining RGD and KRSR Sequences Improves Osteoblastic Functions by Synergizing Integrin and Cell-Membrane Proteoglycan Binding.

Mireia Hoyos-Nogués, Elena Falgueras-Batlle, Maria-Pau Ginebra, José María Manero, Javier Gil, Carlos Mas-Moruno

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. KRSR and RGD Adsorption on TiOBiomolecules · 2026
    Article
  3. The dental implant surface: a review of the past, present and future.Journal of materials science. Materials in medicine · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. The nanomorphology of cell surfaces of adhered osteoblasts.Beilstein journal of nanotechnology · 2021
    Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Mireia Hoyos-NoguésBiomaterials, Biomechanics and Tissue Engineering Group (BBT), Department of Materials Science and Metallurgical Engineering, Universitat Politècnica de Catalunya (UPC), 08019 Barcelona, Spain. mhoyos@uic.es.ORCID 0000-0003-4221-5643
Elena Falgueras-BatlleBiomaterials, Biomechanics and Tissue Engineering Group (BBT), Department of Materials Science and Metallurgical Engineering, Universitat Politècnica de Catalunya (UPC), 08019 Barcelona, Spain. elena.falgueras9@gmail.com.
Maria-Pau GinebraBiomaterials, Biomechanics and Tissue Engineering Group (BBT), Department of Materials Science and Metallurgical Engineering, Universitat Politècnica de Catalunya (UPC), 08019 Barcelona, Spain. maria.pau.ginebra@upc.edu.ORCID 0000-0002-4700-5621
José María ManeroBiomaterials, Biomechanics and Tissue Engineering Group (BBT), Department of Materials Science and Metallurgical Engineering, Universitat Politècnica de Catalunya (UPC), 08019 Barcelona, Spain. jose.maria.manero@upc.edu.
Javier GilBiomaterials, Biomechanics and Tissue Engineering Group (BBT), Department of Materials Science and Metallurgical Engineering, Universitat Politècnica de Catalunya (UPC), 08019 Barcelona, Spain. xavier.gil@uic.cat.
Carlos Mas-MorunoBiomaterials, Biomechanics and Tissue Engineering Group (BBT), Department of Materials Science and Metallurgical Engineering, Universitat Politècnica de Catalunya (UPC), 08019 Barcelona, Spain. carles.mas.moruno@upc.edu.ORCID 0000-0001-8337-0872
Universitat Politècnica de Catalunya · ESUniversitat Internacional de Catalunya · ES

Funding

Agència de Gestió d'Ajuts Universitaris i de Recerca 2017 SGR-116533Agència de Gestió d'Ajuts Universitaris i de Recerca ICREA academia fellowship of M.-P.G.Ministerio de Economía y Competitividad MAT2015-67183-RMinisterio de Economía y Competitividad MAT2017-83905-RMinisterio de Economía y Competitividad Ramon y Cajal grant of C.M.-M.
6 · The paper itself

Abstract

Synergizing integrin and cell-membrane heparan sulfate proteoglycan signaling on biomaterials through peptidic sequences is known to have beneficial effects in the attachment and behavior of osteoblasts; however, controlling the exact amount and ratio of peptides tethered on a surface is challenging. Here, we present a dual molecular-based biointerface combining integrin (RGD) and heparin (KRSR)-binding peptides in a chemically controlled fashion. To this end, a tailor-made synthetic platform (PLATF) was designed and synthesized by solid-phase methodologies. The PLATF and the control linear peptides (RGD or KRSR) were covalently bound to titanium via silanization. Physicochemical characterization by means of contact angle, Raman spectroscopy and XPS proved the successful and stable grafting of the molecules. The biological potential of the biointerfaces was measured with osteoblastic (Saos-2) cells both at short and long incubation periods. Biomolecule grafting (either the PLATF, RGD or KRSR) statistically improved (

Indexed as

Cell AdhesionCell LineCell MembraneCell MovementCell ProliferationChemical PhenomenaCoated Materials, BiocompatibleExtracellular MatrixIntegrinsOligopeptidesOsteoblastsProteoglycansSpectrum Analysisarginyl-glycyl-aspartic acidCoated Materials, BiocompatibleIntegrinslysyl-arginyl-seryl-arginineOligopeptidesProteoglycansbiointerfacecoatingfunctionalizationintegrinKRSRosteoblastosteointegrationproteoglycanRGDtitanium

Identifiers

PMID30901841
PMCPMC6470513
OpenAlexW2923766951

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.